Several other promising CAR T-cell tumor targets were identified, including alpha-fetoprotein (AFP), Epithelial cell adhesion molecule (EpCAM), Claudin18.2 (CLD18), CD133, and c-MET61. Here, EPCAM is linked to neoplasm.